IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis

Journal of Leukocyte Biology

Volumn 92, Issue 2, 2012, Pages 375-387

  Pascual, David W ^a   Skyberg, Jerod A ^a   Thornburg, Theresa ^a   Kochetkova, Irina ^a   Layton, William ^b   Callis, Gayle ^a   Rollins, MaryClare F ^a   Riccardi, Carol ^a   Becker, Todd ^a   Golden, Sarah ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b Montana Veterinary Diagnostic Laboratory   (United States)

Author keywords

Arthritis; Brucella; Osteomyelitis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL PERITONITIS; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; IMMUNOMODULATION; INFECTION SENSITIVITY; INFLAMMATION; MOUSE; MOUTH INFECTION; MUSCULOSKELETAL DISEASE; NONHUMAN; NOSE INFECTION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN CONTENT; SKIN INFLAMMATION; SOFT TISSUE INFLAMMATION; TISSUE HOMOGENATE; TISSUE LEVEL; TISSUE NECROSIS;

ANIMALS; BRUCELLOSIS; CELLS, CULTURED; DERMATITIS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOSITIS; RABBITS;

BRUCELLA; BRUCELLA MELITENSIS; BRUCELLA MELITENSIS BIOVAR ABORTUS; MUS;

EID: 84864745227     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1211626     Document Type: Article

References (79)

1. Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L., Tsianos, E.V. (2006) The new global map of human brucellosis. Lancet Infect. Dis. 6, 91-99.
2. Chomel, B.B., DeBess, E.E., Mangiamele, D.M., Reilly, K.F., Farver, T.B., Sun, R.K., Barrett, L.R. (1994) Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J. Infect. Dis. 170, 1216-1223.
3. Corbel, M.J. (1997) Brucellosis: an overview. Emerg. Infect. Dis. 3, 213-221.
4. Colmenero, J.D., Reguera, J.M., Fernandez-Nebro, A., Cabrera-Fran-quelo, F. (1991) Osteoarticular complications of brucellosis. Ann. Rheum. Dis. 50, 23-26.
5. Ariza, J., Corredoira, J., Pallares, R., Viladrich, P.F., Rufi, G., Pujol, M., Gudiol, F. (1995) Characteristics of and risk factors for relapse of brucellosis in humans. Clin. Infect. Dis. 20, 1241-1249.
6. Sauret, J.M., Vilissova, N. (2002) Human brucellosis. J. Am. Board Fam. Pract. 15, 401-406.
7. Rajapakse, C.N. (1995) Bacterial infections: osteoarticular brucellosis. Baillieres Clin. Rheumatol. 9, 161-177.
8. Gotuzzo, E., Alarcon, G.S., Bocanegra, T.S., Carrillo, C., Guerra, J.C., Rolando, I., Espinoza, L.R. (1982) Articular involvement in human brucellosis: a retrospective analysis of 304 cases. Semin. Arthritis Rheum. 12, 245-255.
9. Shaalan, M.A., Memish, Z.A., Mahmoud, S.A., Alomari, A., Khan, M.Y., Almuneef, M., Alalola, S. (2002) Brucellosis in children: clinical observations in 115 cases. Int. J. Infect. Dis. 6, 182-186.
10. al Eissa, Y.A., Kambal, A.M., Alrabeeah, A.A., Abdullah, A.M., al Ju-rayyan, N.A., al Jishi, N.M. (1990) Osteoarticular brucellosis in children. Ann. Rheum. Dis. 49, 896-900.
11. Bosilkovski, M., Krteva, L., Caparoska, S., Dimzova, M. (2004) Osteoar-ticular involvement in brucellosis: study of 196 cases in the Republic of Macedonia. Croat. Med. J. 45, 727-733.
12. Martin-Hernandez, C., Ballester-Jimerez, J., Espallargas-Doñate, T., Fuertes-Vallcorba, A. (2009) Arthroscopic synovectomy, an alternative in the treatment of brucellar arthritis of the knee with prolonged course. A report of two cases. Int. J. Orthopedic Surg. 13.
13. Celik, A.D., Celik, Y., Yulugkural, Z., Balci, K., Utku, U. (2008) Acute onset myositis associated with brucellosis, quite a rare diagnosis. Intern. Med. 47, 2091-2093.
14. Akcali, C., Savas, L., Baba, M., Turunc, T., Seckin, D. (2007) Cutaneous manifestations in brucellosis: a prospective study. Adv. Ther. 24, 706-711.
15. Metin, A., Akdeniz, H., Buzgan, T., Delice, I. (2001) Cutaneous findings encountered in brucellosis and review of the literature. Int. J. Dermatol. 40, 434-438.
16. Ayaslioglu, E., Ozluk, O., Kilic, D., Kaygusuz, S., Kara, S., Aydin, G., Cokca, F., Tekeli, E. (2005) A case of brucellar septic arthritis of the knee with a prolonged clinical course. Rheumatol. Int. 25, 69-71.
17. Andonopoulos, A.P., Asimakopoulos, G., Anastasiou, E., Bassaris, H.P. (1986) Brucella arthritis. Scand. J. Rheumatol. 15, 377-380.
18. Yagupsky, P., Peled, N. (2002) Use of the Isolator 1.5 microbial tube for detection of Brucella melitensis in synovial fluid. J. Clin. Microbiol. 40, 3878.
19. Coventry, M.B., Ivins, J.C. (1949) Infection of the hip by Brucella suis. J. Am. Med. Assoc. 141, 320-325.
20. Tissi, L., Puliti, M., Barluzzi, R., Orefici, G., von Hunolstein, C, Bistoni, F. (1999) Role of tumor necrosis factor α, interleukin-1β, and interleu-kin-6 in a mouse model of group B streptococcal arthritis. Infect. Immun. 67, 4545-4550.
21. Burger, D., Dayer, J.M., Palmer, G., Gabay, C. (2006) Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract. Res. Clin. Rheumatol. 20, 879-896.
22. Puliti, M., von Hunolstein, C, Bistoni, F., Orefici, G., Tissi, L. (2004) Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice. Infect. Immun. 72, 4891-4894.
23. Osiri, M., Ruxrungtham, K, Nookhai, S., Ohmoto, Y., Deesomchok, U. (1998) IL-1β, IL-6 and TNF-α in synovial fluid of patients with nongonococcal septic arthritis. Asian Pac. J. Allergy Immunol. 16, 155-160.
24. Beck, G., Benach, J.L., Habicht, G.S. (1989) Isolation of interleukin 1 from joint fluids of patients with Lyme disease. J. Rheumatol. 16, 800-806.
25. Miller, L.C., Lynch, E.A., Isa, S., Logan, J.W., Dinarello, C.A., Steere, A.C. (1993) Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341, 146-148.
26. Norrby-Teglund, A., Thulin, P., Gan, B.S., Kotb, M., McGeer, A, Ander-sson, J., Low, D.E. (2001) Evidence for superantigen involvement in severe group a streptococcal tissue infections. J. Infect. Dis. 184, 853-860.
27. Marshall, B.G., Wangoo, A., Cook, H.T., Shaw, R.J. (1996) Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 51, 1253-1261.
28. Jiang, X., Baldwin, C.L. (1993) Effects of cytokines on intracellular growth of Brucella abortus. Infect. Immun. 61, 124-134.
29. Zhan, Y.F., Stanley, E.R., Cheers, C. (1991) Prophylaxis or treatment of experimental brucellosis with interleukin-1. Infect. Immun. 59, 1790-1794.
30. Delpino, M.V., Fossati, C.A., Baldi, P.C. (2009) Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with Brucella spp. Infect. Immun. 77, 984-995.
31. Wallach, J.C., Delpino, M.V., Scian, R, Deodato, B., Fossati, C.A., Baldi, C. (2010) Prepatellar bursitis due to Brucella abortus: case report and analysis of the local immune response. J. Med. Microbiol. 59, 1514-1518.
32. Wang, X., Hone, D.M., Haddad, A, Shata, M.T., Pascual, D.W. (2003) M cell DNA vaccination for CTL immunity to HIV. J. Immunol. 171, 4717-4725.
33. Clapp, B., Skyberg, J.A., Yang, X., Thornburg, T., Walters, N., Pascual, D.W. (2011) Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses. Infect. Immun. 79, 4165-4174.
34. Tissi, L., Bistoni, F., Puliti, M. (2009) IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection. Mediators Inflamm. 2009, 394021.
35. + regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 184,7144-7153.
36. Ochoa-Repáraz, J., Rynda, A, Ascón, M.A., Yang, X., Kochetkova, I., Riccardi, C., Callis, G., Trunkle, T., Pascual, D.W. (2008) IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J. Immunol. 181, 954-968.
37. Kochetkova, I., Trunkle, T., Callis, G., Pascual, D.W. (2008) Vaccination without autoantigen protects against collagen II-induced arthritis via immune deviation and regulatory T cells. J. Immunol. 181, 2741-2752.
38. Ochoa-Repáraz, J., Riccardi, C, Rynda, A, Jun, S., Callis, G., Pascual, D.W. (2007) Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. 178, 1791-1799.
39. Pascual, D.W., Trunkle, T., Sura, J. (2002) Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages. Infect. Immun. 70, 4273-4281.
40. Lubberts, E., Joosten, L.A, Oppers, B., van den, B.L., Coenen-de Roo, C.J., Kolls, J.K., Schwarzenberger, P., van de Loo, F.A., van den Berg, W.B. (2001) IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167, 1004-1013.
41. Burchill, M.A., Nardelli, D.T., England, D.M., DeCoster, D.J., Chris-topherson, J.A., Callister, S.M., Schell, R.F. (2003) Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect. Immun. 71, 3437-3442.
42. Murphy, E.A., Sathiyaseelan, J., Parent, M.A., Zou, B., Baldwin, C.L. (2001) Interferon-γ is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103, 511-518.
43. Siegmund, B., Sennello, J.A., Lehr, H.A., Senaldi, G., Dinarello, C.A., Fantuzzi, G. (2004) Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR γδ T cells and inter-leukin-18-binding protein. Eur. J. Immunol. 34, 2356-2364.
44. -/-mice. Am. J. Reprod. Immunol. 54, 358-368.
45. Sezak, N., Kuruuzum, Z., Cakir, N., Yuce, A. (2008) Comparison of ri-fampicin and moxifloxacin efficacy in an experimental model of animal brucellosis. J. Chemother. 20, 58-62.
46. De Rycke, J. (1980) Effect of rifampicin and tetracycline alone and in combination against Brucella suis. Ann. Microbiol. (Paris) 131B, 277-287.
47. Agalar, C, Usubutun, S., Turkyilmaz, R. (1999) Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur. J. Clin. Microbiol. Infect. Dis. 18, 535-538.
48. Saltoglu, N., Tasova, Y., Inal, A.S., Seki, T., Aksu, H.S. (2002) Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saudi Med. J. 23, 921-924.
49. Eger, K, Hermes, M., Uhlemann, K., Rodewald, S., Ortwein, J., Brul-port, M., Bauer, A. W., Schormann, W., Lupatsch, F., Schiffer, I.B., Heimerdinger, C.K., Gebhard, S., Spangenberg, C, Prawitt, D., Trost, T., Zabel, B., Sauer, C, Tanner, B., Kolbl, H., Krugel, U., Franke, H., Illes, P., Madaj-Sterba, P., Bockamp, E.O., Beckers, T., Hengstler, J.G. (2004) 4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models. Biochem. Biophys. Res. Commun. 323, 979-986.
50. Geyik, M.F., Gur, A, Nas, K, Cevik, R, Sarac, J., Dikici, B., Ayaz, C. (2002) Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases. Swiss Med. Wkly. 132, 98-105.
51. Maria-Pilar, J.B., Dudal, S., Dornand, J., Gross, A. (2005) Cellular biot-errorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin. Immunol. 114, 227-238.
52. Johnson, B., Mosier, D.A., Morton, R.J., Confer, A.W. (1994) Experimental Brucella abortus strain 19 arthritis in young cattle. J. Vet. Diagn. Invest. 6, 56-61.
53. Smither, S.J., Perkins, S.D., Davies, C., Stagg, A.J., Nelson, M., Atkins, H.S. (2009) Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis. Clin. Vaccine Immunol. 16, 779-783.
54. Rajashekara, G., Glover, D.A., Krepps, M., Splitter, G.A. (2005) Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell. Microbiol. 7, 1459-1473.
55. Paixao, T.A., Roux, C.M., den Hartigh, A.B., Sankaran-Walters, S., Dandekar, S., Santos, R.L., Tsolis, R.M. (2009) Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen. Infect. Immun. 77, 4197-4208.
56. Hedayatizadeh-Omran, A, Rafiei, A, Hajilooi, M., Haghshenas, M. (2010) Interferon-γ low producer genotype +5644 over presented in patients with focal brucellosis. Pak. J. Biol. Sci. 13, 1036-1041.
57. Rafiei, A, Ardestani, S.K., Kariminia, A, Keyhani, A, Mohraz, M., Amirkhani, A. (2006) Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J. Infect. 53, 315-324.
58. Madsen, K.L. (2001) Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin. Invest. Med. 24, 250-257.
59. Johnson, A.J., Roehrig, J.T. (1999) New mouse model for dengue virus vaccine testing. J. Virol. 73, 783-786.
60. Colmenero, J.D., Ruiz-Mesa, J.D., Plata, A, Bermúdez, P., Martin-Rico, P., Queipo-Ortuño, M.I., Reguera, J.M. (2008) Clinical findings, therapeutic approach, and outcome of brucellar vertebral osteomyelitis. Clin. Infect. Dis. 46, 426-433.
61. Al-Shahed, M.S., Sharif, H.S., Haddad, M.C., Aabed, M.Y., Sammak, B.M., Mutairi, M.A. (1994) Imaging features of musculoskeletal brucellosis. Radiographics 14, 333-348.
62. Yagupsky, P. (1999) Detection of brucellae in blood cultures. J. Clin. Microbiol. 37, 3437-3442.
63. Oh, K.B., Nam, K.W., Ahn, H., Shin, J., Kim, S., Mar, W. (2010) Therapeutic effect of (Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylo-nitrile (DMMA) against Staphylococcus aureus infection in a murine model. Biochem. Biophys. Res. Commun. 396, 440-444.
64. Wilson, D.J. (2004) Soft tissue and joint infection. Eur. Radiol. 14 (Suppl 3), E64-E71.
65. Brook, I. (2008) Microbiology and management of soft tissue and muscle infections. Int. J. Surg. 6, 328-338.
66. Nakae, S., Nambu, A, Sudo, K, Iwakura, Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177.
67. Nardelli, D.T., Kevin Luk, K.H., Kotloski, N.J., Warner, T.F., Torre-alba, J.R., Callister, S.M., Schell, R.F. (2008) Role of IL-17, transforming growth factor-β, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borre-lia-vaccinated and -challenged mice. FEMS Immunol. Med. Microbiol. 53, 265-274.
68. Van den Berg, W.B., Joosten, L.A., van de Loo, F.A. (1999) TNF α and IL-1 β are separate targets in chronic arthritis. Clin. Exp. Rheumatol. 17, S105-S114.
69. Hultgren, O., Eugster, H.P., Sedgwick, J.D., Korner, H., Tarkowski, A. (1998) TNF/lymphotoxin-α double-mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J. Immunol. 161, 5937-5942.
70. Skyberg, J.A., Thornburg, T., Rollins, M., Huarte, E., Jutila, M.A., Pas-cual, D.W. (2011) Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections. PLoS ONE 6, e21978.
71. Bongartz, T., Sutton, A.J., Sweeting, M.J., Buchan, I., Matteson, E.L., Montori, V. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295, 2275-2285.
72. Choi, S.W., Ahn, J.J., Hwang, Y.T., Koh, S.H., Cho, S.D. (2009) A case of tuberculous arthritis following the use of etanercept. Korean J. Intern. Med. 24, 397-401.
73. Favero, M., Raffeiner, B., Cecchin, D., Schiavon, F. (2009) Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy. J. Rheumatol. 36, 2846-2847.
74. Solis-Soto, J.M., Quintanilla-Rodriguez, L.E., Meester, I., Segoviano-Ramirez, J.C., Vazquez-Juarez, J.L., Salinas Carmona, M.C. (2008) In situ detection and distribution of inflammatory cytokines during the course of infection with Nocardia brasiliensis. Histol. Histopathol. 23, 573-581.
75. Ahmed, K, Al-Matrouk, K.A., Martinez, G., Oishi, K, Rotimi, V.O., Na-gatake, T. (1999) Increased serum levels of interferon-γ and interleu-kin-12 during human brucellosis. Am. J. Trop. Med. Hyg. 61, 425-427.
76. Mannami, K, Mitsuhashi, T., Takeshita, H., Okada, K, Kuzuhara, A, Yamashita, F., Sakakida, K. (1989) Concentration of interleukin-1 β in serum and synovial fluid in patients with rheumatoid arthritis and those with osteoarthritis. Nippon Seikeigeka Gakkai Zasshi 63, 1343-1352.
77. Oliveira, F.S., Carvalho, N.B., Brandao, A.P., Gomes, M.T., de Almeida, L.A., Oliveira, S.C. (2011) IL-1 receptor-associated kinase 4 (IRAK-4) is essential for initial host control of Brucella abortus infection. Infect. Immun. 79, 4688-4695.
78. Moayeri, M., Crown, D., Newman, Z.L., Okugawa, S., Eckhaus, M., Ca-taisson, C, Liu, S., Sastalla, I., Leppla, S.H. (2010) Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog. 6, e1001222.
79. Joosten, L.A., Netea, M.G., Mylona, E., Koenders, M.I., Malireddi, R.K., Oosting, M., Stienstra, R, van de Veerdonk, F.L., Stalenhoef, A.F., Giamarellos-Bourboulis, E.J., Kanneganti, T.D., van der Meer, J.W. (2010) Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monoso-dium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62, 3237-3248.